The position is embedded in EU-MIC (European Coalition for Mental Health Medicines Innovation), a strategic initiative led by the European College of Neuropsychopharmacology (ECNP). EU-MIC aims to address the growing innovation gap in psychopharmacology between Europe and the United States and to examine the structural disparities between mental and somatic health in access to innovative medicines.
A major workstream of the project focuses on the quantification of the direct and indirect societal costs of mental disorders, including:
The resulting evidence will contribute to scientific publications, European policy reports, and advocacy activities targeting regulators, HTA bodies, payers, policymakers, clinicians, patients, and carers.
The position is initially limited to two years, with the possibility of extending it to three years. There is also the opportunity to pursue a habilitation.
Your Role:
Contact: Prof. Dr. Andreas Reif
Email: reif@med.uni-frankfurt.de
Application Deadline: 25.11.2026
Please submit your application as a single PDF file including:
We welcome applications from candidates of all genders. Women are currently underrepresented in these positions at Universitätsmedizin Frankfurt. Therefore, applications from women are especially encouraged. Applicants with severe disabilities will be given preferential consideration in cases of equal personal and professional qualifications.
HyPlus Solutions GmbH
Union Tank Eckstein GmbH & Co. KG
GRR Garbe Retail Real Estate GmbH
INSITE-Interventions GmbH
Hessische Landgesellschaft mbH
Weisser Ring e. V.
Peter Communication Systems GmbH
ARD MEDIA GmbH